- China
- /
- Medical Equipment
- /
- SHSE:688026
After Leaping 33% Guangzhou Jet Bio-Filtration Co., Ltd. (SHSE:688026) Shares Are Not Flying Under The Radar
Guangzhou Jet Bio-Filtration Co., Ltd. (SHSE:688026) shareholders are no doubt pleased to see that the share price has bounced 33% in the last month, although it is still struggling to make up recently lost ground. Still, the 30-day jump doesn't change the fact that longer term shareholders have seen their stock decimated by the 54% share price drop in the last twelve months.
Following the firm bounce in price, given close to half the companies in China have price-to-earnings ratios (or "P/E's") below 29x, you may consider Guangzhou Jet Bio-Filtration as a stock to avoid entirely with its 54.4x P/E ratio. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.
Guangzhou Jet Bio-Filtration has been struggling lately as its earnings have declined faster than most other companies. One possibility is that the P/E is high because investors think the company will turn things around completely and accelerate past most others in the market. If not, then existing shareholders may be very nervous about the viability of the share price.
Check out our latest analysis for Guangzhou Jet Bio-Filtration
Want the full picture on analyst estimates for the company? Then our free report on Guangzhou Jet Bio-Filtration will help you uncover what's on the horizon.How Is Guangzhou Jet Bio-Filtration's Growth Trending?
In order to justify its P/E ratio, Guangzhou Jet Bio-Filtration would need to produce outstanding growth well in excess of the market.
Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 67%. As a result, earnings from three years ago have also fallen 76% overall. Therefore, it's fair to say the earnings growth recently has been undesirable for the company.
Shifting to the future, estimates from the two analysts covering the company suggest earnings should grow by 229% over the next year. With the market only predicted to deliver 41%, the company is positioned for a stronger earnings result.
With this information, we can see why Guangzhou Jet Bio-Filtration is trading at such a high P/E compared to the market. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.
The Final Word
Shares in Guangzhou Jet Bio-Filtration have built up some good momentum lately, which has really inflated its P/E. While the price-to-earnings ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of earnings expectations.
As we suspected, our examination of Guangzhou Jet Bio-Filtration's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. Unless these conditions change, they will continue to provide strong support to the share price.
We don't want to rain on the parade too much, but we did also find 2 warning signs for Guangzhou Jet Bio-Filtration that you need to be mindful of.
Of course, you might also be able to find a better stock than Guangzhou Jet Bio-Filtration. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:688026
Guangzhou Jet Bio-Filtration
Researches, develops, manufactures, and sells laboratory consumable products.
Proven track record with adequate balance sheet.